Comerica Securities,Inc. Abb Vie Inc. Transaction History

Comerica Securities,Inc.

$1.2 Billion
Q3 2023

A detailed history of Comerica Securities,Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Comerica Securities,Inc. holds 60,901 shares of ABBV stock, worth $11 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

60,901

Previous 65,008 6.32%

Holding current value

$11 Million

Previous $8.76 Million 3.64%

% of portfolio

0.76%

Previous 0.61%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$133.59 - $154.65 $548,654 - $635,147	-4,107 Reduced 6.32%	60,901 $9.08 Million
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $2.04 Million - $2.54 Million	-15,415 Reduced 19.17%	65,008 $8.76 Million
Q1 2023 Apr 27, 2023	SELL	$144.61 - $166.54 $561,809 - $647,007	-3,885 Reduced 4.61%	80,423 $12.8 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $152,002 - $182,291	-1,099 Reduced 1.29%	84,308 $13.6 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $211,783 - $242,901	-1,578 Reduced 1.81%	85,407 $11.5 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $1.59 Million - $2.02 Million	-11,529 Reduced 11.7%	86,985 $13.3 Million
Q1 2022 Apr 28, 2022	SELL	$131.98 - $163.75 $589,026 - $730,816	-4,463 Reduced 4.33%	98,514 $16 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $245,262 - $310,328	2,283 Added 2.27%	102,977 $13.9 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $321,008 - $364,393	3,017 Added 3.09%	100,694 $10.9 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $200,845 - $223,753	-1,909 Reduced 1.92%	97,677 $11 Million
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $579,324 - $637,767	-5,663 Reduced 5.38%	99,586 $10.8 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $139,408 - $188,216	-1,732 Reduced 1.62%	105,249 $11.3 Million
Q3 2020 Nov 04, 2020	BUY	$85.91 - $100.83 $168,555 - $197,828	1,962 Added 1.87%	106,981 $9.37 Million
Q2 2020 Jul 17, 2020	BUY	$73.37 - $98.18 $114,016 - $152,571	1,554 Added 1.5%	105,019 $10.3 Million
Q1 2020 Apr 16, 2020	BUY	$64.5 - $97.79 $92,944 - $140,915	1,441 Added 1.41%	103,465 $7.88 Million
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $5.24 Million - $6.56 Million	72,699 Added 247.91%	102,024 $9.03 Million
Q3 2019 Oct 15, 2019	SELL	$62.98 - $75.72 $1.25 Million - $1.5 Million	-19,846 Reduced 40.36%	29,325 $2.22 Million
Q3 2019 Oct 15, 2019	BUY	$62.98 - $75.72 $1.42 Million - $1.7 Million	22,502 Added 84.38%	49,171 $4.53 Million
Q2 2019 Aug 09, 2019	SELL	$65.7 - $83.98 $1.33 Million - $1.7 Million	-20,215 Reduced 43.12%	26,669 $1.94 Million
Q1 2019 May 07, 2019	BUY	$77.14 - $90.79 $3.62 Million - $4.26 Million	46,884 New	46,884 $3.78 Million

Others Institutions Holding ABBV

# of Institutions

3,854

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Securities,Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comerica Securities,Inc. with notifications on news.

Account

Comerica Securities,Inc. Abb Vie Inc. Transaction History